Grand Pharmaceutical's new drup for treatment of brain tumors granted approval

>>REAL-TIME UPDATES IN THE WIRE. CLICK HERE<<<

A new drug for the treatment of brain tumors manufactured by Grand Pharmaceutical Group (HK: 0512) has been given the green light by Chinese regulators . . .

Sign In or Subscribe To Get Full Access.

Everything you need about China markets is on THE WIRE - one timeline with up-to-the-minute updates throughout every trading day.

Follow China Market In The Most Efficient Way!

TRY US FOR FREE

For only $0.5 per day, we get a full coverage of key developments in China market, in real time, with data and details you don't see elsewhere. Grab the welcome offer!